Access to medicines and health products

Access to medicines and health products

Universal health coverage can only be achieved when there is affordable access to safe, effective and quality medicines and health products. 

Countries face a range of obstacles to achieving this, including rising prices for new medicines; shortages and stock outs of essential medicines, especially for noncommunicable diseases, and the growing problem of substandard and falsified medical products entering the global supply chain. Added to this, there are other challenges to ensuring that medicines are not only available, but are used appropriately. Antimicrobial resistance has become a worldwide problem largely due to overuse, and misuse of opioids has led to an addiction epidemic in some countries. Knowing where to tackle the problem is the first step. WHO works with Member States to identify what their priorities are on the road to achieving this universal access.

Departments

Health products policy and standards

Regulation and Prequalification

News

All →

Publications

All →
The selection and use of essential medicines (2023) - TRS 1049

The 24th meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was held in Geneva, Switzerland, from 24 to 28 April 2023. The...

WHO Expert Committee on Drug Dependence: Forty-sixth report

The Forty-sixth Meeting of the World Health Organisation (WHO)’s Expert Committee on Drug Dependence (ECDD) was convened from 16 to 19 October...

WTO agreements and public health : a joint study by the WHO and WTO secretariat

This comprehensive document deals with the relevant WTO agreements and the way they may influence health and health policies. In undertaking this joint...

World Local Production Forum: Enhancing access to medicines and other health technologies

The World Local Production Forum: Enhancing access to medicines and other health technologies (WLPF) brings the global community – foremost government...